Compositions and methods for treating thymic stromal lymphopoietin (TSLP)-mediated conditions

Details for Australian Patent Application No. 2009308362 (hide)

Owner Revalesio Corporation

Inventors Watson, Richard L.; Wood, Anthony B.; Archambeau, Gregory J.

Agent Davies Collison Cave

Pub. Number AU-A-2009308362

PCT Pub. Number WO2010/048425

Priority 12/258,210 24.10.08 US; 61/107,480 22.10.08 US; 61/107,453 22.10.08 US

Filing date 22 October 2009

Wipo publication date 29 April 2010

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/048425 Priority application(s): WO2010/048425

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308369-Combination treatments comprising protease binding proteins for inflammatory disorders

2009308359-Method for processing electrodes for stimulation lead